Postings

AbbVie—Allergan merger a bad deal for consumers
As the Federal Trade Commission signs off on the $63 billion deal between AbbVie and Allergen, advocates warn that the merger will reduce competition in a number of markets where AbbVie and Allergan directly overlap with each other. The deal will also exacerbate competitive problems that already exist in the pharmaceutical drug industry relating to rebate walls and patent abuses.

All insurers must make coronavirus tests and treatment free to patients
Americans have been urged to seek medical help if they are showing symptoms of COVID-19, but out-of-pocket costs could put insured patients into serious medical debt, or worse, deter them from seeking treatment at all — causing undue suffering and death, and exacerbating the pandemic. A coalition of more than 80 advocacy groups came together to urge all health insurance corporations to waive all patient fees for care associated with COVID-19, including copays and deductibles.

Affordability should be paramount when the COVID-19 vaccine is released to the public
Consumer Action joined nearly 70 organizations in writing to President Trump, asking him to ensure that vaccines or treatments for the coronavirus disease (COVID-19), developed and purchased with U.S. taxpayer dollars, are reasonably priced and available to everyone. Americans will not accept President Trump allowing Big Pharma corporations to profit off a pandemic that continues to claim thousands of lives.

Congress: Pass a clean budget for FY2021
Advocates called on Congress to pass an upcoming federal budget that funds the things that Americans care about, not undo essential consumer and environmental safeguards through policy riders. Policy riders are attached to legislation and rarely have anything to do with the bill. In fact, most riders are handouts to big corporations and special favors for interest groups that could not become law on their own merits. As Congress prepares the federal budget for fiscal year 2021, no appropriations titles, package of bills, or continuing resolutions should pass if they contain poison pill policy riders that go against the public interest, including policies that ensure safe and healthy food, restrain Wall Street abuses, provide access to justice and fair housing, and guarantee access to safe healthcare.

Healthcare mergers result in less choice and higher prescription drug prices for consumers
As the Federal Trade Commission considers signing off on the $63 billion deal between AbbVie and Allergen, advocates warn that the merger will reduce competition in a number of markets where AbbVie and Allergan directly overlap with each other. The deal will also exacerbate competitive problems that already exist in the pharmaceutical drug industry relating to rebate walls and patent abuses.

How the government shutdown puts working families at risk
As the longest federal government shutdown in our nation’s history drags on, advocates raised concern as to how working families could potentially be harmed long after the government reopens its doors. Without a paycheck, federal employees fear losing their homes, consider risky financial loans in lieu of income, tax credits and refunds, and worry about the lasting impact that missed bill payments will have on their credit.

Hands off the Medicare donut hole deal
Consumer Action joined a coalition of over 40 advocates in calling on Congress to reject any measures that would increase prescription drug costs for consumers, including rolling back the provisions in the Bipartisan Budget Act of 2018 that make brand-name prescription drugs more affordable for people with Medicare—specifically the 70% discount required from pharmaceutical companies in the donut hole.

Health insurance tax would hit seniors hard
An approximate $22 billion health insurance tax (HIT) is scheduled to impact 20 million seniors and disabled individuals enrolled in Medicare Advantage in 2020. In a letter, coalition advocates urged Congress to delay the HIT for 2020, otherwise millions of American seniors and others with health insurance coverage could face a major premium increase, including $500 in additional annual premiums for the typical Medicare Advantage couple.

Modernizing Medicare education tools empowers seniors
Coalition advocates urged the Centers for Medicare & Medicaid Services (CMS) to continue its efforts to improve and enhance the information and decision-making tools available to Medicare beneficiaries, in order to better enable seniors to make informed decisions and become active choosers in their health coverage.

The Choice Act 2.0 is the WRONG choice for consumers
Advocates are urging Congress to oppose the so-called Financial Choice Act 2.0, that aims to repeal parts and eviscerate parts of the 2010 Dodd-Frank Wall Street Reform and Consumer Protection Act, including the centerpiece Consumer Financial Protection Bureau. The (Wrong) Choice Act would grind the CFPB to a halt by turning it into a gridlocked Commission, and eliminate its independent funding. This irresponsible assault takes all the worst ideas and combines them into one toxic package.

Search

Quick Menu

Facebook FTwitter T
 

Consumer Help Desk

Advocacy